-
1 Comment
Clover Corporation Limited is currently in a long term uptrend where the price is trading 9.5% above its 200 day moving average.
From a valuation standpoint, the stock is 42.6% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.9.
Clover Corporation Limited's total revenue sank by 21.7% to $29M since the same quarter in the previous year.
Its net income has dropped by 45.8% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 223.1% to $3M since the same quarter in the previous year.
Based on the above factors, Clover Corporation Limited gets an overall score of 3/5.
ISIN | AU000000CLV2 |
---|---|
Exchange | AU |
CurrencyCode | AUD |
Sector | Consumer Defensive |
Industry | Packaged Foods |
Dividend Yield | 3.4% |
---|---|
Beta | 0.07 |
Market Cap | 73M |
PE Ratio | 14.67 |
Target Price | 0.6 |
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm, a microencapsulated powders with the addition of Hi-DHA tuna and/or algal oils. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CLV.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025